Group 4 Created with Sketch.

Jonathan Corren, MD and Paul Yamauchi, MD - Advances in the Management of Allergic and Inflammatory Diseases: Highlights From Washington, DC

39:35
Play Audio
Add to Playlist
Share Report
Snippets are a new way to share audio!
You can clip a small part of any file to share, add to playlist, and transcribe automatically. Just click the to create your snippet!
Top Snippets - Jonathan Corren, MD and Paul Yamauchi, MD - Advances in the Management of Allergic and Inflammatory Diseases: Highlights From Washington, DC
Found on these Playlists
Best Paul Yamauchi Interviews on Podcasts or Audio about Paul Listen to audio about Paul Yamauchi. Browse for Paul Yamauchi interviews, guest appearances, and call-ins. Make snippets of Paul talking to create audio highlights to share with your friends or embed in related blog posts. Vurbl People: Interviews, Commentary, News, and More
Best Jonathan Corren Interviews on Podcasts or Audio about Jonathan Listen to audio about Jonathan Corren. Browse for Jonathan Corren interviews, guest appearances, and call-ins. Make snippets of Jonathan talking to create audio highlights to share with your friends or embed in related blog posts. Vurbl People: Interviews, Commentary, News, and More
Full Description
Back to Top
Go online to PeerView.com/NCE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in allergy and dermatology discuss advances in the management of allergic and inflammatory diseases presented at the 2019 American Academy of Dermatology Annual Meeting and the American Academy of Allergy, Asthma & Immunology 2019 Annual Meeting. Upon completion of this activity, participants will be able to: Describe the relationship between type 2 inflammatory disorders, including atopic dermatitis, asthma, chronic rhinosinusitis and nasal polyps (CRS/NP), and eosinophilic esophagitis (EoE), Discuss emerging data related to the efficacy and safety of therapies for the treatment of allergic and inflammatory diseases, Apply the latest clinical data to the treatment of patients with allergic and inflammatory disorders, such as atopic dermatitis, asthma, CRS/NP, and EoE.